Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease
Author:
Affiliation:
1. Inflammatory Bowel Disease Center; University of Chicago Medicine; Chicago IL USA
2. Takeda Pharmaceuticals International, Inc.; Deerfield IL USA
3. RTI Health Solutions; Research Triangle Park NC USA
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12727/fullpdf
Reference26 articles.
1. Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population;Kappelman;Dig Dis Sci,2013
2. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002;Herrinton;Am J Gastroenterol,2008
3. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings;Herrinton;Inflamm Bowel Dis,2007
4. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States;Kappelman;Clin Gastroenterol Hepatol,2007
5. The burden of inflammatory bowel disease in the United States: a moving target?;Loftus;Clin Gastroenterol Hepatol,2007
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Common Mistakes in Managing Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2024-08-14
2. Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn’s Disease in the Phase 2 AMAG Study;Inflammatory Bowel Diseases;2024-08-02
3. Peripheral blood DNA methylation signatures predict response to vedolizumab and ustekinumab in adult patients with Crohn’s disease: The EPIC-CD study;2024-07-25
4. Evaluating Inadequate Therapy Response in Ulcerative Colitis Adult Patients: A Retrospective Analysis of German Health Claims Data on Advanced Therapy Initiation;2024-07-22
5. The economic impact of suboptimal treatment and treatment switch among patients with Crohn’s disease treated with a first-line biologic – A US retrospective claims database study;Journal of Medical Economics;2024-07-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3